Table of Contents
1 Brain Tumor Treatment Market Overview
1.1 Product Overview and Scope of Brain Tumor Treatment
1.2 Classification of Brain Tumor Treatment by Type
1.2.1 Global Brain Tumor Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Brain Tumor Treatment Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Chemotherapy
1.2.6 Immunotherapy
1.2.7 Others
1.3 Global Brain Tumor Treatment Market by Application
1.3.1 Overview: Global Brain Tumor Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Brain Tumor Treatment Market by Regions
1.4.1 Global Brain Tumor Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Brain Tumor Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Brain Tumor Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Tumor Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Genetech (U.S.)
2.1.1 Genetech (U.S.) Details
2.1.2 Genetech (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genetech (U.S.) SWOT Analysis
2.1.4 Genetech (U.S.) Product and Services
2.1.5 Genetech (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck (U.S.)
2.2.1 Merck (U.S.) Details
2.2.2 Merck (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck (U.S.) SWOT Analysis
2.2.4 Merck (U.S.) Product and Services
2.2.5 Merck (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca (India)
2.3.1 Astra Zeneca (India) Details
2.3.2 Astra Zeneca (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca (India) SWOT Analysis
2.3.4 Astra Zeneca (India) Product and Services
2.3.5 Astra Zeneca (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol Mayers Squibb (U.S.)
2.4.1 Bristol Mayers Squibb (U.S.) Details
2.4.2 Bristol Mayers Squibb (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol Mayers Squibb (U.S.) SWOT Analysis
2.4.4 Bristol Mayers Squibb (U.S.) Product and Services
2.4.5 Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Antisenese Pharma (Mongolia)
2.5.1 Antisenese Pharma (Mongolia) Details
2.5.2 Antisenese Pharma (Mongolia) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Antisenese Pharma (Mongolia) SWOT Analysis
2.5.4 Antisenese Pharma (Mongolia) Product and Services
2.5.5 Antisenese Pharma (Mongolia) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hoffman-La Roche (Switzerland)
2.6.1 Hoffman-La Roche (Switzerland) Details
2.6.2 Hoffman-La Roche (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hoffman-La Roche (Switzerland) SWOT Analysis
2.6.4 Hoffman-La Roche (Switzerland) Product and Services
2.6.5 Hoffman-La Roche (Switzerland) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mankind Pharma (India)
2.7.1 Mankind Pharma (India) Details
2.7.2 Mankind Pharma (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mankind Pharma (India) SWOT Analysis
2.7.4 Mankind Pharma (India) Product and Services
2.7.5 Mankind Pharma (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis (Switzerland)
2.8.1 Novartis (Switzerland) Details
2.8.2 Novartis (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis (Switzerland) SWOT Analysis
2.8.4 Novartis (Switzerland) Product and Services
2.8.5 Novartis (Switzerland) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer (U.S.)
2.9.1 Pfizer (U.S.) Details
2.9.2 Pfizer (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer (U.S.) SWOT Analysis
2.9.4 Pfizer (U.S.) Product and Services
2.9.5 Pfizer (U.S.) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mcleod’s Pharmaceuticals (India)
2.10.1 Mcleod’s Pharmaceuticals (India) Details
2.10.2 Mcleod’s Pharmaceuticals (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mcleod’s Pharmaceuticals (India) SWOT Analysis
2.10.4 Mcleod’s Pharmaceuticals (India) Product and Services
2.10.5 Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Dr. Reddy’s Laboratories (India)
2.11.1 Dr. Reddy’s Laboratories (India) Details
2.11.2 Dr. Reddy’s Laboratories (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Dr. Reddy’s Laboratories (India) SWOT Analysis
2.11.4 Dr. Reddy’s Laboratories (India) Product and Services
2.11.5 Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Brain Tumor Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Brain Tumor Treatment Players Market Share
3.2.2 Top 10 Brain Tumor Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Brain Tumor Treatment Revenue and Market Share by Regions
4.2 North America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5 North America Brain Tumor Treatment Revenue by Countries
5.1 North America Brain Tumor Treatment Revenue by Countries (2015-2020)
5.2 USA Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6 Europe Brain Tumor Treatment Revenue by Countries
6.1 Europe Brain Tumor Treatment Revenue by Countries (2015-2020)
6.2 Germany Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.4 France Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Brain Tumor Treatment Revenue by Countries
7.1 Asia-Pacific Brain Tumor Treatment Revenue by Countries (2015-2020)
7.2 China Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.5 India Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
8 South America Brain Tumor Treatment Revenue by Countries
8.1 South America Brain Tumor Treatment Revenue by Countries (2015-2020)
8.2 Brazil Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Brain Tumor Treatment by Countries
9.1 Middle East & Africa Brain Tumor Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Brain Tumor Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Brain Tumor Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Brain Tumor Treatment Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
10.6 Immunotherapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Brain Tumor Treatment Market Segment by Application
11.1 Global Brain Tumor Treatment Revenue Market Share by Application (2015-2020)
11.2 Brain Tumor Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Brain Tumor Treatment Market Size Forecast (2021-2025)
12.1 Global Brain Tumor Treatment Market Size Forecast (2021-2025)
12.2 Global Brain Tumor Treatment Market Forecast by Regions (2021-2025)
12.3 North America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.6 South America Brain Tumor Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Brain Tumor Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
【掲載企業】
Genetech (U.S.)、Merck (U.S.)、Astra Zeneca (India)、Bristol Mayers Squibb (U.S.)、Antisenese Pharma (Mongolia)、Hoffman-La Roche (Switzerland)、Mankind Pharma (India)、Novartis (Switzerland)、Pfizer (U.S.)、Mcleod’s Pharmaceuticals (India)、Dr. Reddy’s Laboratories (India)
【免責事項】
https://www.globalresearch.jp/disclaimer